Bacteria Are Blind To Politics
In Eliminating Antibiotic Support From COVID-19 Aid Package, US Congress Has ‘Failed to be Decisive And Forward-Thinking’
Executive Summary
Evan Loh, CEO of infectious disease drug developer Paratek Pharmaceuticals, explains why eliminating the DISARM ACT, which focused on finding solutions against antimicrobial resistance, from the new coronavirus aid package is a shortsighted move by US congress.